AVTR - Avantor expands bioproduction footprint in China with RIM Bio acquisition

Avantor (AVTR) announced the acquisition of RIM Bio, a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. The terms of the deal were not disclosed.RIM Bio will be Avantor’s first single-use production plant in the AMEA region adding to its existing single-use manufacturing network in the Americas and Europe, the company said.“RIM serves as an anchor for us to build our presence in this key region, as we better position Avantor to capture long-term opportunities in the growing, global Bioproduction space," noted Dr. Ger Brophy, executive vice president, Biopharma Production at Avantor.In December 2019, Avantor unveiled an innovation and customer support center in Shanghai, China.

For further details see:

Avantor expands bioproduction footprint in China with RIM Bio acquisition